Clicking the "View this Article" button will open the issue as a resizable PDF. To take the test for
the issue, return to this Introduction page and click the "Take the Test" button. The Introduction
page will remain open after you open this issue.
You may need to re-size or close the issue in order to see the Introduction page.
Cannabis has been legalized, decriminalized or approved for medical use in every US state except Alabama, Idaho, Kansas, South Carolina, Tennessee, Wisconsin,and Wyoming. The number of medical Cannabis users in the US is somewhere between 3 and 9 million. A review of individual states’ registries shows that the overwhelming majority of medical cannabis users are managing pain. Because most registries are designed to access and track tetrahydrocannabinol (THC)-type Cannabis products, the reasons for using cannabidiol (CBD) products are less clear. An online survey of 2,409 patients found that CBD was used for a variety of medical conditions, most frequently chronic pain, arthritis/joint pain, and anxiety.Although medical Cannabis may not be an item offered in most pharmacies, the American Pharmacy Association (APhA) released a policy statement in 2015 advocating for pharmacists to “collect and document information in the pharmacy patient profile about the use of Cannabis and its various components and provide appropriate patient counseling.” Many health care providers feel there isn’t enough information about Cannabis available to support evidence-based decision making. While that may be true, health care providers can participate in the collection of practice-based evidence and patient experience, as suggested by the APhA. This facilitates shared decision making and supports the effort to achieve optimal health care. This issue provides an overview of the physiological and clinical effects of Cannabis-based compounds and dosage forms. It is intended to help providers counsel patients about the potential benefit, or lack of benefit, of Cannabis for various types of chronic pain, and discuss safety considerations.
This program was developed by The Rx Consultant and published by Continuing Education Network, Inc. The Rx Consultant accepts no advertising or financial support from the pharmaceutical industry and is funded solely by the purchase of programs. The Rx Consultant is dedicated to providing unbiased, balanced information to health care practitioners.
Programs developed by The Rx Consultant are written by health care providers with expertise in the topic area, peer-reviewed, extensively edited, and fact-checked. This development process was created to insure that every program presents information that is current, accurate, relevant to "real world" health care providers, and written in an easy reading, "plain English" style.
The Rx Consultant is a publication of Continuing Education Network, Inc.
ACPE Universal Activity Number: 0428-0000-20-011-H01-P
Chief Editor and CE Administrator
Terry M. Baker, PharmD
Tracy Farnen, PharmD
James Chan, PharmD, PhD
Pharmacy Quality and Outcomes Coordinator
Associate Clinical Professor
Richard Ron Finley, B.S. Pharm.,R.Ph.
Consult Pharmacist Aging and Adult Health Services
Julio R. Lopez, PharmD, FCSHP
Adjunct Clinical Professor
Assistant Clinical Professor
Visiting Associate Professor and Lecturer
Pamela Mausner, MD
Helen Berlie, Pharm.D. CDE, BCACP
Ambulatory Care Specialist - Diabetes
Senior Editorial Advisor
Gerard Hatheway, PharmD, PhD
Belinda M. Danielson, RPh
Christopher M. DeSoto, PharmD
Angie S. Graham, PharmD
Cynthia Chan Huang, PharmD, MBA
Fred Plageman, PharmD
Editorial Advisor and Clinical Practice Consultant for Nurse Practitioners
Meuleman, RN, C, MS
Any hardware that supports Microsoft Windows, Apple Mac OS, iOS, or Android, and meets the software requirements.
Browser that supports TLS 1.1 + and PDF files.
This includes Microsoft Internet Explorer 11, Google Chrome 38, Google Android OS 5.0 Browser, Apple Safari (version 7 for desktop, 5 for mobile), Mozilla Firefox 27, newer versions of these browsers, as well as some earlier versions that may require additional configuration.
Adobe Acrobat Reader is recommended, and is required for some browsers.
Note: TLS 1.1 and 1.2 support is required for browser security. Click here for TLS browser support details.
Required. Broadband recommended. (T1, DSL, Cable, G4 or higher.)